The aim of this study is to investigate the continuous analgesic effect and side effects of ropivacaine combined with hydromorphone for combined spinal-epidural anesthesia(CSEA) after total knee arthroplasty and to explore its clinical application value. To observe whether hydromorphone combined with ropivacaine can promote the rapid recovery of patients.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Incidence of moderate to severe pain at rest at 6, 12, 18, and 24 hours after anesthesia.
Timeframe: 6, 12, 18, and 24 hours after anesthesia
Incidence of moderate to severe pain with movement at 6, 12, 18, and 24 hours after anesthesia.
Timeframe: 6, 12, 18, and 24 hours after anesthesia